187 related articles for article (PubMed ID: 19711582)
1. Management of relapsed mantle cell lymphoma: still a treatment challenge.
Ruan J; Coleman M; Leonard JP
Oncology (Williston Park); 2009 Jul; 23(8):683-90. PubMed ID: 19711582
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
Dawar R; Hernandez-Ilizaliturri F
Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
[TBL] [Abstract][Full Text] [Related]
3. Treatment options for mantle cell lymphoma.
Smolewski P; Witkowska M; Robak T
Expert Opin Pharmacother; 2015; 16(16):2497-507. PubMed ID: 26360791
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: the promise of new treatment options.
Goy A; Kahl B
Crit Rev Oncol Hematol; 2011 Oct; 80(1):69-86. PubMed ID: 21168343
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and management of temsirolimus in patients with relapsed or refractory mantle cell lymphoma.
Coiffier B
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):351-9. PubMed ID: 23763923
[TBL] [Abstract][Full Text] [Related]
6. [Mantle Cell Lymphoma - Cutting edge Dia-gnostics and Treatment Approaches].
Klener P; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S80-6. PubMed ID: 26489506
[TBL] [Abstract][Full Text] [Related]
7. The current therapeutic scenario for relapsed mantle cell lymphoma.
Ferrero S; Dreyling M
Curr Opin Oncol; 2013 Sep; 25(5):452-62. PubMed ID: 23872784
[TBL] [Abstract][Full Text] [Related]
8. Treatment strategies in mantle cell lymphoma.
Maddocks K; Blum KA
Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
[TBL] [Abstract][Full Text] [Related]
9. [Current treatment strategy in mantle cell lymphoma].
Ogura M
Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
[TBL] [Abstract][Full Text] [Related]
10. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
Lenz G; Dreyling M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond.
Zhou Y; Zhang L; Romaguera J; Delasalle K; Han X; Du X; Kwak L; Yi Q; Wang M
Am J Hematol; 2008 Feb; 83(2):144-9. PubMed ID: 17722077
[TBL] [Abstract][Full Text] [Related]
13. Temsirolimus in mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.
Hess G; Smith SM; Berkenblit A; Coiffier B
Semin Oncol; 2009 Dec; 36 Suppl 3():S37-45. PubMed ID: 19963099
[TBL] [Abstract][Full Text] [Related]
14. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
Avivi I; Goy A
Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
[TBL] [Abstract][Full Text] [Related]
15. Unmet needs in the treatment of mantle cell lymphoma.
Rosen ST; Link BK; Fowler NH
Clin Adv Hematol Oncol; 2013 Nov; 11(11 Suppl 18):1-19. PubMed ID: 24893041
[TBL] [Abstract][Full Text] [Related]
16. Therapies for mantle cell lymphoma: current challenges and a brighter future.
Skarbnik AP; Smith MR
Discov Med; 2013 Mar; 15(82):177-87. PubMed ID: 23545046
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
18. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
19. Integrating emerging treatment options in mantle cell lymphoma.
Kahl BS; Fowler NH; Czuczman MS
Clin Adv Hematol Oncol; 2013 Dec; 11(12 Suppl 19):1-15. PubMed ID: 24893155
[TBL] [Abstract][Full Text] [Related]
20. Current treatment approaches for mantle-cell lymphoma.
Witzig TE
J Clin Oncol; 2005 Sep; 23(26):6409-14. PubMed ID: 16155027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]